JP2015522544A5 - - Google Patents

Download PDF

Info

Publication number
JP2015522544A5
JP2015522544A5 JP2015513123A JP2015513123A JP2015522544A5 JP 2015522544 A5 JP2015522544 A5 JP 2015522544A5 JP 2015513123 A JP2015513123 A JP 2015513123A JP 2015513123 A JP2015513123 A JP 2015513123A JP 2015522544 A5 JP2015522544 A5 JP 2015522544A5
Authority
JP
Japan
Prior art keywords
alkyl
optionally substituted
group
aromatic heterocycle
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015513123A
Other languages
English (en)
Japanese (ja)
Other versions
JP6204977B2 (ja
JP2015522544A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2013/060282 external-priority patent/WO2013174757A1/en
Publication of JP2015522544A publication Critical patent/JP2015522544A/ja
Publication of JP2015522544A5 publication Critical patent/JP2015522544A5/ja
Application granted granted Critical
Publication of JP6204977B2 publication Critical patent/JP6204977B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015513123A 2012-05-25 2013-05-17 三級アミン、前記アミンを含む薬物、その使用及びその調製方法 Active JP6204977B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12169577 2012-05-25
EP12169577.9 2012-05-25
PCT/EP2013/060282 WO2013174757A1 (en) 2012-05-25 2013-05-17 Tertiary amines, medicaments containing said amines, use thereof and processes for the preparation thereof

Publications (3)

Publication Number Publication Date
JP2015522544A JP2015522544A (ja) 2015-08-06
JP2015522544A5 true JP2015522544A5 (enExample) 2016-07-07
JP6204977B2 JP6204977B2 (ja) 2017-09-27

Family

ID=48539098

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015513123A Active JP6204977B2 (ja) 2012-05-25 2013-05-17 三級アミン、前記アミンを含む薬物、その使用及びその調製方法

Country Status (4)

Country Link
US (1) US9078909B2 (enExample)
EP (1) EP2861577B1 (enExample)
JP (1) JP6204977B2 (enExample)
WO (1) WO2013174757A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1993360T (pt) 2005-12-28 2017-05-25 Vertex Pharma Formas sólidas de n-[2,4-bis(1,1-dimetiletil)-5-hidroxifenil]-1,4-di-hidro-4-oxoquinolina-3-carboxamida
EP2991981B1 (en) * 2013-04-30 2017-03-01 Boehringer Ingelheim International GmbH Diaminopyrazine compounds, medicaments containing said compounds, use thereof and processes for the preparation thereof
PT3131582T (pt) 2014-04-15 2018-10-08 Vertex Pharma Composições farmacêuticas para o tratamento de doenças mediadas pelo regulador de condutância transmembranar da fibrose quística
CN107250113B (zh) 2014-10-07 2019-03-29 弗特克斯药品有限公司 囊性纤维化跨膜传导调节蛋白的调节剂的共晶
CN115028661A (zh) * 2022-05-19 2022-09-09 上海应用技术大学 一种4-氨基哌啶-1-甲基磷酸酯及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6812003A (enExample) 1967-09-07 1969-03-11
US3953476A (en) 1971-12-27 1976-04-27 Merck & Co., Inc. 3-Amino-5-sulfonylbenzoic acids
AU2001229501A1 (en) 2000-01-24 2001-07-31 Isis Pharmaceuticals, Inc. Antisense modulation of inducible nitric oxide synthase expression
AU2004264441A1 (en) * 2003-08-18 2005-02-24 Parion Sciences, Inc. Cyclic pyrazinoylguanidine sodium channel blockers
GB0526240D0 (en) * 2005-12-22 2006-02-01 Novartis Ag Organic compounds
AU2008248598B2 (en) 2007-05-07 2011-11-17 Novartis Ag Organic compounds
US8664228B2 (en) 2008-05-13 2014-03-04 Novartis Ag 3,5-diamino-6-chloro-pyrazine-2-carboxylic acid derivatives and their use as epithelial sodium channel blockers for the treatment of airway diseases
BR112013032771B1 (pt) 2011-06-27 2021-01-12 Parion Sciences, Inc. dipeptídio quimicamente e metabolicamente estável possuindo potente atividade bloqueadora de canais de sódio
AR086745A1 (es) 2011-06-27 2014-01-22 Parion Sciences Inc 3,5-diamino-6-cloro-n-(n-(4-(4-(2-(hexil(2,3,4,5,6-pentahidroxihexil)amino)etoxi)fenil)butil)carbamimidoil)pirazina-2-carboxamida

Similar Documents

Publication Publication Date Title
JP2014037426A5 (enExample)
JP2015522544A5 (enExample)
JP2016532677A5 (enExample)
JP2015503609A5 (enExample)
WO2009115517A3 (en) Pyridines and pyrazines as inhibitors of pi3k
JP2013531031A5 (enExample)
HRP20240937T1 (hr) Heteroaril spoj sa kondeziranim prstenom i njihova primjena kao trk inhibitora
EA025158B1 (ru) Гетероциклические соединения, лекарственные средства, содержащие указанные соединения, их применение и способы их получения
JP2014511892A5 (enExample)
PE20161475A1 (es) Pirazolopiridinas y pirazolopirimidinas
JP2006524660A5 (enExample)
SMT201300097B (it) Inibitori delle chinasi map p38
JP2015526453A5 (enExample)
MX394360B (es) Inhibidores de jak2 y alk2 y metodos para su uso.
JP2016527220A5 (enExample)
JP2019509276A5 (enExample)
JP2013510120A5 (enExample)
JP2014534222A5 (enExample)
SI2989100T1 (en) NAFTIRIDINE DERIVATIVES USED AS ANTAGONISTS INTEGRITY OF ALFA-V-BETA-6
JP2013523802A5 (enExample)
TN2016000090A1 (en) Substituted quinolizine derivatives useful as hiv integrase inhibitors.
SI3024819T1 (en) Glyoxamide-substituted pyrrolamide derivatives and their use as medicines for the treatment of hepatitis B
JP2011530493A5 (enExample)
JP2017522348A5 (enExample)
JP2015526455A5 (enExample)